{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:40:22Z","timestamp":1756363222640,"version":"3.44.0"},"reference-count":32,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,5,17]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>A man in his 40s presented to the emergency department after 2\u2009weeks of abdominal pain and bloating. Radiological investigations revealed multiple unusual sites of thrombosis, including large thrombi in his portal and mesenteric veins, and a left ventricular thrombus with resultant embolic infarcts to his spleen, kidneys, coronary arteries and brain. Standard causes of underlying thrombophilia were excluded. A serum protein electrophoresis and serum-free light chains, with subsequent bone marrow biopsy, lead to the diagnosis of smouldering multiple myeloma (sMM), albeit an unusual presentation with severe clinical sequelae. Although sMM is known to be associated with an increased risk of venous thromboembolism, it is not recognised to cause thrombosis in both venous and arterial vascular beds simultaneously. Physicians encountering patients with multiple thrombi in unusual vascular beds without clear aetiology should consider an underlying monoclonal gammopathy in their list of differentials.<\/jats:p>","DOI":"10.1136\/bcr-2024-260061","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T21:10:49Z","timestamp":1717708249000},"page":"e260061","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Massive arterial and venous thrombosis from smouldering multiple myeloma: further evidence for monoclonal gammopathy of thrombotic significance"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6587-5661","authenticated-orcid":false,"given":"Jolie","family":"Kun","sequence":"first","affiliation":[{"name":"School of Medicine, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3545-4235","authenticated-orcid":false,"given":"Jonathan","family":"Hunter","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Queensland, Brisbane, Queensland, Australia"},{"name":"Internal Medicine, Redcliffe Hospital, Redcliffe, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"2025082723070070000_17.6.e260061.1","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/j.crvasa.2013.03.001","article-title":"Prevention of arterial and venous thrombosis in cancer patients","volume":"55","author":"Aschermann","year":"2013","journal-title":"Cor Vasa"},{"key":"2025082723070070000_17.6.e260061.2","article-title":"DVT as the initial presentation of multiple myeloma: a rare case report and literature review","volume":"15","author":"Khalil","year":"2023","journal-title":"Cureus"},{"key":"2025082723070070000_17.6.e260061.3","doi-asserted-by":"crossref","unstructured":"Sun Y , Kroll MH . Cardiology Secrets. 5th edn.2018:534\u20139.","DOI":"10.1016\/B978-0-323-47870-0.00062-3"},{"key":"2025082723070070000_17.6.e260061.4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020480","article-title":"Monoclonal gammopathy of thrombotic significance","volume":"15","author":"Gkalea","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025082723070070000_17.6.e260061.5","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.437"},{"key":"2025082723070070000_17.6.e260061.6","unstructured":"eTg . Venous thromboembolism (VTE) treatment. 2023. Available: https:\/\/tgldcdp-tg-org-au.ap1.proxy.openathens.net\/viewTopic?etgAccess=true&guidelinePage=Cardiovascular&topicfile=cardiovascular-disease-risk-stratification&guidelinename=auto\u00a7ionId=c_CVG_Venous-thromboembolism-treatmenttopic_24#c_CVG_Venous-thromboembolism-treatmenttopic_24"},{"key":"2025082723070070000_17.6.e260061.7","unstructured":"eTg . Heart failure with reduced ejection fraction (HFrEF). 2023. Available: https:\/\/tgldcdp-tg-org-au.ap1.proxy.openathens.net\/viewTopic?etgAccess=true&guidelinePage=Cardiovascular&topicfile=c_CVG_Heart-failure-with-reduced-ejection-fractiontopic_1&guidelinename=Cardiovascular\u00a7ionId=toc_d1e402#toc_d1e402"},{"key":"2025082723070070000_17.6.e260061.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.046"},{"key":"2025082723070070000_17.6.e260061.9","unstructured":"International Myeloma Foundation . Types of myeloma studio city, California, USA. 2021. Available: https:\/\/www.myeloma.org\/types-of-myeloma"},{"key":"2025082723070070000_17.6.e260061.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003"},{"key":"2025082723070070000_17.6.e260061.11","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2025082723070070000_17.6.e260061.12","unstructured":"International Myeloma Foundation . International myeloma working group (IMWG) criteria for the diagnosis of multiple myeloma Studio City, California, USA. 2014. Available: https:\/\/www.myeloma.org\/international-myeloma-working-group-imwg-criteria-diagnosis-multiple-myeloma"},{"key":"2025082723070070000_17.6.e260061.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"2025082723070070000_17.6.e260061.14","unstructured":"International Myeloma Foundation . What are MGUS, smouldering multiple myeloma, and active myeloma? Studio Ctiy, California, USA. 2021. Available: https:\/\/www.myeloma.org\/what-are-mgus-smm-mm"},{"key":"2025082723070070000_17.6.e260061.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01539.x"},{"key":"2025082723070070000_17.6.e260061.16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.thromres.2021.03.015","article-title":"Prothrombotic abnormalities in patients with multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"202","author":"Nielsen","year":"2021","journal-title":"Thromb Res"},{"key":"2025082723070070000_17.6.e260061.17","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-022-00719-0","article-title":"Smoldering multiple myeloma current treatment algorithms","volume":"12","author":"Rajkumar","year":"2022","journal-title":"Blood Cancer J"},{"key":"2025082723070070000_17.6.e260061.18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/hematology.2021000304","article-title":"Smoldering multiple myeloma: evolving diagnostic criteria and treatment strategies","volume":"2021","author":"Visram","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2025082723070070000_17.6.e260061.19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215247","article-title":"Monoclonal gammopathies of clinical significance: a critical appraisal","volume":"14","author":"R\u00edos-Tamayo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025082723070070000_17.6.e260061.20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1045002","article-title":"Monoclonal gammopathies of clinical significance (MGCS): in pursuit of optimal treatment","volume":"13","author":"Oganesyan","year":"2022","journal-title":"Front Immunol"},{"key":"2025082723070070000_17.6.e260061.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-839480"},{"key":"2025082723070070000_17.6.e260061.22","first-page":"243","article-title":"Monoclonal gammopathy of renal significance (Mgrs): histopathologic classification, diagnostic workup, and therapeutic options","volume":"77","author":"Amaador","year":"2019","journal-title":"Neth J Med"},{"key":"2025082723070070000_17.6.e260061.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2019.100471","article-title":"\u201cMonoclonal gammopathy of \u201cocular\u201d significance\u201d","volume":"15","author":"Karakus","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025082723070070000_17.6.e260061.24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jdv.13847","article-title":"Monoclonal gammopathy of cutaneous significance: review of a relevant concept","volume":"31","author":"Lipsker","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025082723070070000_17.6.e260061.25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/cjn.2020.278","article-title":"Monoclonal gammopathies of \u2018neurological significance\u2019: paraproteinemic neuropathies","volume":"48","author":"Mani","year":"2021","journal-title":"Can J Neurol Sci"},{"key":"2025082723070070000_17.6.e260061.26","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00513-4","article-title":"Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy","volume":"11","author":"Chakraborty","year":"2021","journal-title":"Blood Cancer J"},{"key":"2025082723070070000_17.6.e260061.27","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12168"},{"key":"2025082723070070000_17.6.e260061.28","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1179\/102453312X13336169156933","article-title":"Thrombosis in multiple myeloma (MM)","volume":"17 Suppl 1","author":"Cesarman-Maus","year":"2012","journal-title":"Hematology"},{"key":"2025082723070070000_17.6.e260061.29","doi-asserted-by":"crossref","unstructured":"Wu X , Yin Y , Teng J , et al . IgMk paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay: a case report. BMC Immunol 2017;18. doi:10.1186\/s12865-017-0213-0","DOI":"10.1186\/s12865-017-0213-0"},{"key":"2025082723070070000_17.6.e260061.30","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199910)62:2<99::AID-AJH6>3.0.CO;2-N"},{"key":"2025082723070070000_17.6.e260061.31","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/236913","article-title":"Pulmonary embolism as the first manifestation of multiple myeloma","volume":"2013","author":"Vallianou","year":"2013","journal-title":"Case Rep Med"},{"key":"2025082723070070000_17.6.e260061.32","unstructured":"Ye X . Venous thromboembolism as the first presentation of multiple myeloma. Int Soc Thrombosis Haemostasis 2021;5 (Suppl 2)."}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-260061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:07:13Z","timestamp":1756361233000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-260061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,6]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1136\/bcr-2024-260061"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-260061","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}